Abstract
Half a century ago, chronic granulomatous disease (CGD) was first described as a disease fatally affecting the ability of children to survive infections. Various milestone discoveries have since been made, from an insufficient ability of patients’ leucocytes to kill microbes to the underlying genetic abnormalities1. In this inherited disorder, phagocytes lack NADPH oxidase activity and do not generate reactive oxygen species, most notably superoxide anion, causing recurrent bacterial and fungal infections. Patients with CGD also suffer from chronic inflammatory conditions, most prominently granuloma formation in hollow viscera. The precise mechanisms of the increased microbial pathogenicity have been unclear2, and more so the reasons for the exaggerated inflammatory response3,4,5,6. Here we show that a superoxide-dependent step in tryptophan metabolism along the kynurenine pathway is blocked in CGD mice with lethal pulmonary aspergillosis, leading to unrestrained Vγ1+ γδ T-cell reactivity, dominant production of interleukin (IL)-17, defective regulatory T-cell activity and acute inflammatory lung injury. Although beneficial effects are induced by IL-17 neutralization or γδ T-cell contraction, complete cure and reversal of the hyperinflammatory phenotype are achieved by replacement therapy with a natural kynurenine distal to the blockade in the pathway. Effective therapy, which includes co-administration of recombinant interferon-γ (IFN-γ), restores production of downstream immunoactive metabolites and enables the emergence of regulatory Vγ4+ γδ and Foxp3+ αβ T cells. Therefore, paradoxically, the lack of reactive oxygen species contributes to the hyperinflammatory phenotype associated with NADPH oxidase deficiencies, through a dysfunctional kynurenine pathway of tryptophan catabolism. Yet, this condition can be reverted by reactivating the pathway downstream of the superoxide-dependent step.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Assari, T. Chronic granulomatous disease; fundamental stages in our understanding of CGD. Med. Immunol. 5, 4 (2006)
Chang, Y. C., Segal, B. H., Holland, S. M., Miller, G. F. & Kwon-Chung, K. J. Virulence of catalase-deficient Aspergillus nidulans in p47 phox-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J. Clin. Invest. 101, 1843–1850 (1998)
Romani, L. Immunity to fungal infections. Nature Rev. Immunol. 4, 1–23 (2004)
Marciano, B. E. et al. Long-term interferon-γ therapy for patients with chronic granulomatous disease. Clin. Infect. Dis. 39, 692–699 (2004)
Ott, M. G. et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Med. 12, 401–409 (2006)
Bylund, J. et al. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-κB. Eur. J. Immunol. 37, 1087–1096 (2007)
Grohmann, U., Fallarino, F. & Puccetti, P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol. 24, 242–248 (2003)
Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762–774 (2004)
Grohmann, U. et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nature Med. 13, 579–586 (2007)
Sharma, M. D. et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117, 2570–2582 (2007)
Schwarcz, R. & Pellicciari, R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 303, 1–10 (2002)
Stone, T. W. & Darlington, L. G. Endogenous kynurenines as targets for drug discovery and development. Nature Rev. Drug Discov. 1, 609–620 (2002)
Munn, D. H. et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22, 633–642 (2005)
Platten, M. et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310, 850–855 (2005)
Puccetti, P. & Grohmann, U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation. Nature Rev. Immunol. 7, 817–823 (2007)
Popov, A. et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J. Clin. Invest. 116, 3160–3170 (2006)
Belladonna, M. L. et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J. Immunol. 177, 130–137 (2006)
Born, W. K., Reardon, C. L. & O’Brien, R. L. The function of γδ T cells in innate immunity. Curr. Opin. Immunol. 18, 31–38 (2006)
Lockhart, E., Green, A. M. & Flynn, J. L. IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662–4669 (2006)
Shibata, K., Yamada, H., Hara, H., Kishihara, K. & Yoshikai, Y. Resident Vδ1+ γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466–4472 (2007)
Fallarino, F. et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9, 1069–1077 (2002)
Fallarino, F. et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752–6761 (2006)
De Luca, A. et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc . J. Immunol. 179, 5999–6008 (2007)
Kirby, A. C., Newton, D. J., Carding, S. R. & Kaye, P. M. Pulmonary dendritic cells and alveolar macrophages are regulated by γδ T cells during the resolution of S. pneumoniae-induced inflammation. J. Pathol. 212, 29–37 (2007)
Andrew, E. M. & Carding, S. R. Murine γδ T cells in infections: beneficial or deleterious? Microbes Infect. 7, 529–536 (2005)
Peterman, G. M., Spencer, C., Sperling, A. I. & Bluestone, J. A. Role of γδ T cells in murine collagen-induced arthritis. J. Immunol. 151, 6546–6558 (1993)
Andrew, E. M. et al. Delineation of the function of a major γδ T cell subset during infection. J. Immunol. 175, 1741–1750 (2005)
Hizawa, N., Kawaguchi, M., Huang, S. K. & Nishimura, M. Role of interleukin-17F in chronic inflammatory and allergic lung disease. Clin. Exp. Allergy 36, 1109–1114 (2006)
Hultqvist, M., Backlund, J., Bauer, K., Gelderman, K. A. & Holmdahl, R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J. Immunol. 179, 1431–1437 (2007)
Montagnoli, C. et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol. 176, 1712–1723 (2006)
Jackson, S. H., Gallin, J. I. & Holland, S. M. The p47 phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182, 751–758 (1995)
Bellocchio, S. et al. TLRs govern neutrophil activity in aspergillosis. J. Immunol. 173, 7406–7415 (2004)
Romani, L. et al. Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 108, 2265–2274 (2006)
Morgenstern, D. E., Gifford, M. A., Li, L. L., Doerschuk, C. M. & Dinauer, M. C. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus . J. Exp. Med. 185, 207–218 (1997)
Spieker-Polet, H., Sethupathi, P., Yam, P. C. & Knight, K. L. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit–rabbit hybridomas. Proc. Natl Acad. Sci. USA 92, 9348–9352 (1995)
Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunol. 4, 1206–1212 (2003)
Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo . Nature Immunol. 3, 1097–1101 (2002)
Tramonti, D., Andrew, E. M., Rhodes, K., Newton, D. J. & Carding, S. R. Evidence for the opposing roles of different γδ T cell subsets in macrophage homeostasis. Eur. J. Immunol. 36, 1729–1738 (2006)
Jackson, S. H. et al. IFN-γ is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD). J. Interferon Cytokine Res. 21, 567–573 (2001)
Acknowledgements
This work was supported by Specific Targeted Research Project ‘MANASP’ (L.R.), and funding from the Juvenile Diabetes Research Foundation (P.P.) We thank P. Mosci for maintaining the mutant strains of mice and performing histopathology; and G. Andrielli for digital art and image editing.
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Supplementary Information
The file contains Supplementary Notes with additional references; Supplementary Figures S1-S5 with Legends, including a schematic Figure S2a that summarizes the main rationale of the study and Supplementary Tables S1-S5. (PDF 2453 kb)
Rights and permissions
About this article
Cite this article
Romani, L., Fallarino, F., De Luca, A. et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451, 211–215 (2008). https://doi.org/10.1038/nature06471
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature06471
This article is cited by
-
Multiple reaction monitoring assays for large-scale quantitation of proteins from 20 mouse organs and tissues
Communications Biology (2024)
-
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia
Nature Communications (2023)
-
Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells
Nature Communications (2022)
-
The role of indoleamine 2,3‐dioxygenase in allergic disorders
Molecular Biology Reports (2022)
-
Autoimmunity in Primary Immunodeficiencies (PID)
Clinical Reviews in Allergy & Immunology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.